Batten Disease News and Research

RSS
Batten disease (also known as Spielmeyer-Vogt-Sjögren-Batten disease) is a rare, fatal autosomal recessive neurodegenerative disorder that begins in childhood. It is the most common form of a group of disorders called neuronal ceroid lipofuscinosis (or NCLs).
BDSRA designates Nationwide Children's Hospital as Batten Disease Center of Excellence

BDSRA designates Nationwide Children's Hospital as Batten Disease Center of Excellence

Raptor initiates enrollment in pivotal Phase 3 clinical trial of DR Cysteamine for nephropathic cystinosis

Raptor initiates enrollment in pivotal Phase 3 clinical trial of DR Cysteamine for nephropathic cystinosis

Raptor Pharmaceutical acquires exclusive license to intellectual property for Huntington's Disease treatment

Raptor Pharmaceutical acquires exclusive license to intellectual property for Huntington's Disease treatment

STEM reports net loss of $6,124,000 for first-quarter 2010: MicroStockProfit.com

STEM reports net loss of $6,124,000 for first-quarter 2010: MicroStockProfit.com

StemCells first-quarter total revenue up 307%

StemCells first-quarter total revenue up 307%

Neural stem cell transplantation promising for Batten disease

Neural stem cell transplantation promising for Batten disease

StemCells to initiate second clinical trial of HuCNS-SC human neural stem cells in NCL

StemCells to initiate second clinical trial of HuCNS-SC human neural stem cells in NCL

StemCells reports net loss of $5.23M for fourth-quarter fiscal 2009

StemCells reports net loss of $5.23M for fourth-quarter fiscal 2009

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Human neural stem cells to treat Pelizaeus-Merzbacher Disease

Human neural stem cells to treat Pelizaeus-Merzbacher Disease

StemCells’ novel neuroprotective approach for treating neurodegenerative diseases

StemCells’ novel neuroprotective approach for treating neurodegenerative diseases

Febit's DNA-capture method selected by NCGR to re-sequence 400 genes involved in childhood diseases

Febit's DNA-capture method selected by NCGR to re-sequence 400 genes involved in childhood diseases

Stemcells, Inc. reports Q2 financials

Stemcells, Inc. reports Q2 financials

Launch of new foundation for Batten disease

Launch of new foundation for Batten disease

New hope for Batten disease sufferers

New hope for Batten disease sufferers

New ray of hope for children with Batten disease

New ray of hope for children with Batten disease

Rochester receives $1.2 million to battle rare childhood disease

Rochester receives $1.2 million to battle rare childhood disease

Rochester now offers gene test to detect Batten disease

Rochester now offers gene test to detect Batten disease

Researchers track human stem cells transplanted into rat brain

Researchers track human stem cells transplanted into rat brain

New hope for Krabbe disease sufferers

New hope for Krabbe disease sufferers